Global Antibody-drug Conjugate Professional Survey Report 2022, Forecast to 2027

Code: RW00014781166
Multimarket Insight
Aug-2022
Life Sciences
102 Pages

Antibody-drug conjugates?or?ADCs?are a class of?biopharmaceutical?drugs designed as a?targeted therapy?for treating cancer.[1]?Unlike?chemotherapy, ADCs are intended to target and kill tumor cells while sparing healthy cells. As of 2019, some 56 pharmaceutical companies were developing ADCs.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Antibody-drug Conjugate industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Adcetris
Kadcyla

Market Segment by Product Application
Breast Cancer
Lymphoma

Finally, the report provides detailed profile and data information analysis of leading company.
ImmunoGen
Takeda
Seattle Genetics
Roche

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Antibody-drug Conjugate consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Antibody-drug Conjugate market by identifying its various subsegments.
3.Focuses on the key global Antibody-drug Conjugate manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Antibody-drug Conjugate with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Antibody-drug Conjugate submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Antibody-drug Conjugate Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Antibody-drug Conjugate Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Antibody-drug Conjugate Segment by Type
2.1.1 Adcetris
2.1.2 Kadcyla
2.2 Market Analysis by Application
2.2.1 Breast Cancer
2.2.2 Lymphoma
2.3 Global Antibody-drug Conjugate Market Comparison by Regions (2017-2027)
2.3.1 Global Antibody-drug Conjugate Market Size (2017-2027)
2.3.2 North America Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.3 Europe Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.4 Asia-pacific Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.5 South America Antibody-drug Conjugate Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Antibody-drug Conjugate Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Antibody-drug Conjugate Industry Impact
2.5.1 Antibody-drug Conjugate Business Impact Assessment - Covid-19
2.5.2 Market Trends and Antibody-drug Conjugate Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Antibody-drug Conjugate Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Antibody-drug Conjugate Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Antibody-drug Conjugate Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Antibody-drug Conjugate Manufacturer Market Share
3.5 Top 10 Antibody-drug Conjugate Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
3.7 Key Manufacturers Antibody-drug Conjugate Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Antibody-drug Conjugate Industry Key Manufacturers
4.1 ImmunoGen
4.1.1 Company Details
4.1.2 ImmunoGen Antibody-drug Conjugate Product Introduction, Application and Specification
4.1.3 ImmunoGen Antibody-drug Conjugate Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 ImmunoGen News
4.2 Takeda
4.2.1 Company Details
4.2.2 Takeda Antibody-drug Conjugate Product Introduction, Application and Specification
4.2.3 Takeda Antibody-drug Conjugate Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Takeda News
4.3 Seattle Genetics
4.3.1 Company Details
4.3.2 Seattle Genetics Antibody-drug Conjugate Product Introduction, Application and Specification
4.3.3 Seattle Genetics Antibody-drug Conjugate Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Seattle Genetics News
4.4 Roche
4.4.1 Company Details
4.4.2 Roche Antibody-drug Conjugate Product Introduction, Application and Specification
4.4.3 Roche Antibody-drug Conjugate Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Roche News

5 Global Antibody-drug Conjugate Sales Categorized by Regions
5.1 Global Antibody-drug Conjugate Revenue, Sales and Market Share by Regions
5.1.1 Global Antibody-drug Conjugate Sales and Market Share by Regions (2017-2022)
5.1.2 Global Antibody-drug Conjugate Revenue and Market Share by Regions (2017-2022)
5.2 North America Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
5.3 Europe Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
5.5 South America Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Antibody-drug Conjugate Sales and Growth Rate (2017-2022)

6 North America Antibody-drug Conjugate Market Size Categorized by Countries
6.1 North America Antibody-drug Conjugate Sales, Revenue and Market Share by Countries
6.1.1 North America Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
6.1.2 North America Antibody-drug Conjugate Revenue by Countries (2017-2022)
6.1.3 United States Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
6.1.4 Canada Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
6.1.5 Mexico Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
6.2 North America Antibody-drug Conjugate Revenue (Value) by Manufacturers
6.3 North America Antibody-drug Conjugate Sales and Market Share by Type (2017-2022)
6.4 North America Antibody-drug Conjugate Sales Market Share by Application (2017-2022)

7 Europe Antibody-drug Conjugate Market Size Categorized by Countries
7.1 Europe Antibody-drug Conjugate Sales, Revenue and Market Share by Countries
7.1.1 Europe Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Antibody-drug Conjugate Revenue by Countries (2017-2022)
7.1.3 Germany Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
7.1.4 UK Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
7.1.5 France Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
7.1.6 Russia Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
7.1.7 Italy Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
7.1.8 Spain Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
7.2 Europe Antibody-drug Conjugate Revenue (Value) by Manufacturers
7.3 Europe Antibody-drug Conjugate Sales and Market Share by Type (2017-2022)
7.4 Europe Antibody-drug Conjugate Sales Market Share by Application (2017-2022)

8 Asia-Pacific Antibody-drug Conjugate Market Size Categorized by Countries
8.1 Asia-pacific Antibody-drug Conjugate Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Antibody-drug Conjugate Revenue by Countries (2017-2022)
8.1.3 China Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
8.1.4 South Korea Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
8.1.5 Japan Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
8.1.6 Australia Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
8.1.7 India Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Antibody-drug Conjugate Revenue (Value) by Manufacturers
8.3 Asia-pacific Antibody-drug Conjugate Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Antibody-drug Conjugate Sales Market Share by Application (2017-2022)

9 South America Antibody-drug Conjugate Market Size Categorized by Countries
9.1 South America Antibody-drug Conjugate Sales, Revenue and Market Share by Countries
9.1.1 South America Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
9.1.2 South America Antibody-drug Conjugate Revenue by Countries (2017-2022)
9.1.3 Brazil Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
9.2 South America Antibody-drug Conjugate Sales and Market Share by Type (2017-2022)
9.3 South America Antibody-drug Conjugate Sales Market Share by Application (2017-2022)

10 Middle East and Africa Antibody-drug Conjugate Market Size Categorized by Countries
10.1 Middle East and Africa Antibody-drug Conjugate Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Antibody-drug Conjugate Revenue by Countries (2017-2022)
10.1.3 GCC Countries Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
10.1.4 Turkey Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
10.1.5 Egypt Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
10.1.6 South America Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Antibody-drug Conjugate Sales and Market Share by Type
10.3 Middle East and Africa Antibody-drug Conjugate Sales Market Share by Application (2017-2022)

11 Global Antibody-drug Conjugate Market Segment by Type
11.1 Global Antibody-drug Conjugate Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Antibody-drug Conjugate Sales and Market Share by Type (2017-2022)
11.1.2 Global Antibody-drug Conjugate Revenue and Market Share by Type (2017-2022)
11.2 Adcetris Sales Growth Rate and Price
11.2.1 Global Adcetris Sales Growth Rate (2017-2022)
11.2.2 Global Adcetris Price (2017-2022)
11.3 Kadcyla Sales Growth Rate and Price
11.3.1 Global Kadcyla Sales Growth Rate (2017-2022)
11.3.2 Global Kadcyla Price (2017-2022)

12 Global Antibody-drug Conjugate Market Segment by Application
12.1 Global Antibody-drug Conjugate Sales Market Share by Application (2017-2022)
12.2 Breast Cancer Sales Growth Rate (2017-2022)
12.3 Lymphoma Sales Growth Rate (2017-2022)

13 Global Antibody-drug Conjugate Market Forecast
13.1 Global Antibody-drug Conjugate Revenue, Sales and Growth Rate (2022-2027)
13.2 Antibody-drug Conjugate Market Forecast by Regions (2022-2027)
13.2.1 North America Antibody-drug Conjugate Market Forecast (2022-2027)
13.2.2 Europe Antibody-drug Conjugate Market Forecast (2022-2027)
13.2.3 Asia-Pacific Antibody-drug Conjugate Market Forecast (2022-2027)
13.2.4 South America Antibody-drug Conjugate Market Forecast (2022-2027)
13.2.5 Middle East & Africa Antibody-drug Conjugate Market Forecast (2022-2027)
13.3 Antibody-drug Conjugate Market Forecast by Type (2022-2027)
13.3.1 Global Antibody-drug Conjugate Sales Forecast by Type (2022-2027)
13.3.2 Global Antibody-drug Conjugate Market Share Forecast by Type (2022-2027)
13.4 Antibody-drug Conjugate Market Forecast by Application (2022-2027)
13.4.1 Global Antibody-drug Conjugate Sales Forecast by Application (2022-2027)
13.4.2 Global Antibody-drug Conjugate Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Antibody-drug Conjugate Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Antibody-drug Conjugate Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Antibody-drug Conjugate
Figure Market Concentration Ratio and Market Maturity Analysis of Antibody-drug Conjugate
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Antibody-drug Conjugate Market Size by Type
Figure Global Market Share of Antibody-drug Conjugate by Type in 2021
Figure Adcetris Picture
Figure Kadcyla Picture
Table Global Antibody-drug Conjugate Market Size (Volume) by Application
Figure Breast Cancer Picture
Figure Lymphoma Picture
Table Global Antibody-drug Conjugate Comparison by Regions (M USD) 2017-2027
Figure Global Antibody-drug Conjugate Market Size (Million US$) (2017-2027)
Figure North America Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Antibody-drug Conjugate Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Antibody-drug Conjugate Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Antibody-drug Conjugate Sales by Manufacturer (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Manufacturer in 2021
Table Global Antibody-drug Conjugate Revenue by Manufacturer (2017-2022)
Figure Global Antibody-drug Conjugate Revenue Market Share by Manufacturer in 2021
Table Global Antibody-drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Antibody-drug Conjugate Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Antibody-drug Conjugate Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
Table Key Manufacturers Antibody-drug Conjugate Product Type
Table Mergers & Acquisitions Planning
Table ImmunoGen Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of ImmunoGen
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ImmunoGen 2017-2022
Table ImmunoGen Main Business
Table ImmunoGen Recent Development
Table Takeda Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of Takeda
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takeda 2017-2022
Table Takeda Main Business
Table Takeda Recent Development
Table Seattle Genetics Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of Seattle Genetics
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Seattle Genetics 2017-2022
Table Seattle Genetics Main Business
Table Seattle Genetics Recent Development
Table Roche Company Profile
Table Antibody-drug Conjugate Product Introduction, Application and Specification of Roche
Table Antibody-drug Conjugate Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2017-2022
Table Roche Main Business
Table Roche Recent Development
Figure Global Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Global Antibody-drug Conjugate Revenue and Growth Rate (2017-2022)
Table Global Antibody-drug Conjugate Sales by Regions (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Regions in 2021
Table Global Antibody-drug Conjugate Revenue by Regions (2017-2022)
Figure Global Antibody-drug Conjugate Revenue Market Share by Regions in 2021
Figure North America Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Europe Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Asia-pacific Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure South America Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure North America Antibody-drug Conjugate Revenue and Growth Rate (2017-2022)
Table North America Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
Table North America Antibody-drug Conjugate Sales Market Share by Countries (2017-2022)
Figure North America Antibody-drug Conjugate Sales Market Share by Countries in 2021
Table North America Antibody-drug Conjugate Revenue by Countries (2017-2022)
Table North America Antibody-drug Conjugate Revenue Market Share by Countries (2017-2022)
Figure North America Antibody-drug Conjugate Revenue Market Share by Countries in 2021
Figure United States Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Canada Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Mexico Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Table North America Antibody-drug Conjugate Revenue by Manufacturer (2021)
Figure North America Antibody-drug Conjugate Revenue Market Share by Manufacturer in 2021
Table North America Antibody-drug Conjugate Sales by Type (2017-2022)
Table North America Antibody-drug Conjugate Sales Share by Type (2017-2022)
Table North America Antibody-drug Conjugate Sales by Application (2017-2022)
Table North America Antibody-drug Conjugate Sales Share by Application (2017-2022)
Figure Europe Antibody-drug Conjugate Revenue and Growth Rate (2017-2022)
Table Europe Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
Table Europe Antibody-drug Conjugate Sales Market Share by Countries (2017-2022)
Figure Europe Antibody-drug Conjugate Sales Market Share by Countries in 2021
Table Europe Antibody-drug Conjugate Revenue by Countries (2017-2022)
Table Europe Antibody-drug Conjugate Revenue Market Share by Countries (2017-2022)
Figure Europe Antibody-drug Conjugate Revenue Market Share by Countries in 2021
Figure Germany Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure UK Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure France Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Russia Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Italy Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Spain Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Table Europe Antibody-drug Conjugate Revenue by Manufacturer (2021)
Figure Europe Antibody-drug Conjugate Revenue Market Share by Manufacturer in 2021
Table Europe Antibody-drug Conjugate Sales by Type (2017-2022)
Table Europe Antibody-drug Conjugate Sales Share by Type (2017-2022)
Table Europe Antibody-drug Conjugate Sales by Application (2017-2022)
Table Europe Antibody-drug Conjugate Sales Share by Application (2017-2022)
Figure Asia-pacific Antibody-drug Conjugate Revenue and Growth Rate (2017-2022)
Table Asia-pacific Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Antibody-drug Conjugate Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Antibody-drug Conjugate Sales Market Share by Countries in 2021
Table Asia-pacific Antibody-drug Conjugate Revenue by Countries (2017-2022)
Table Asia-pacific Antibody-drug Conjugate Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Antibody-drug Conjugate Revenue Market Share by Countries in 2021
Figure China Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure South Korea Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Japan Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Australia Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure India Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Southeast Asia Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Table Asia-pacific Antibody-drug Conjugate Revenue by Manufacturer (2021)
Figure Asia-pacific Antibody-drug Conjugate Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Antibody-drug Conjugate Sales by Type (2017-2022)
Table Asia-pacific Antibody-drug Conjugate Sales Share by Type (2017-2022)
Table Asia-pacific Antibody-drug Conjugate Sales by Application (2017-2022)
Table Asia-pacific Antibody-drug Conjugate Sales Share by Application (2017-2022)
Figure South America Antibody-drug Conjugate Revenue and Growth Rate (2017-2022)
Table South America Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
Table South America Antibody-drug Conjugate Sales Market Share by Countries (2017-2022)
Figure South America Antibody-drug Conjugate Sales Market Share by Countries in 2019
Table South America Antibody-drug Conjugate Revenue by Countries (2017-2022)
Table South America Antibody-drug Conjugate Revenue Market Share by Countries (2017-2022)
Figure South America Antibody-drug Conjugate Revenue Market Share by Countries in 2019
Figure Brazil Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Table South America Antibody-drug Conjugate Sales by Type (2017-2022)
Table South America Antibody-drug Conjugate Sales Share by Type (2017-2022)
Table South America Antibody-drug Conjugate Revenue by Type (2017-2022)
Table South America Antibody-drug Conjugate Revenue Share by Type (2017-2022)
Table South America Antibody-drug Conjugate Sales by Application (2017-2022)
Table South America Antibody-drug Conjugate Sales Share by Application (2017-2022)
Figure Middle East and Africa Antibody-drug Conjugate Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Antibody-drug Conjugate Sales Market Share by Countries in 2019
Table Middle East and Africa Antibody-drug Conjugate Revenue by Countries (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Countries in 2019
Figure GCC Countries Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Turkey Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure Egypt Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Figure South Africa Antibody-drug Conjugate Sales and Growth Rate (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Sales by Type (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Sales Share by Type (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Revenue by Type (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Revenue Share by Type (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Sales by Application (2017-2022)
Table Middle East and Africa Antibody-drug Conjugate Sales Share by Application (2017-2022)
Table Global Antibody-drug Conjugate Sales by Type (2017-2022)
Table Global Antibody-drug Conjugate Sales Market Share by Type (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Type in 2021
Table Global Antibody-drug Conjugate Revenue by Type (2017-2022)
Table Global Antibody-drug Conjugate Revenue Market Share by Type (2017-2022)
Figure Global Antibody-drug Conjugate Revenue Market Share by Type in 2019
Figure Global Adcetris Sales Growth Rate (2017-2022)
Figure Global Adcetris Price (2017-2022)
Figure Global Kadcyla Sales Growth Rate (2017-2022)
Figure Global Kadcyla Price (2017-2022)
Table Global Antibody-drug Conjugate Sales by Application (2017-2022)
Table Global Antibody-drug Conjugate Sales Market Share by Application (2017-2022)
Figure Global Antibody-drug Conjugate Sales Market Share by Application in 2021
Figure Global Breast Cancer Sales Growth Rate (2017-2022)
Figure Global Lymphoma Sales Growth Rate (2017-2022)
Figure Global Antibody-drug Conjugate Sales and Growth Rate (2022-2027)
Figure Global Antibody-drug Conjugate Revenue and Growth Rate (2022-2027)
Table Global Antibody-drug Conjugate Sales Forecast by Regions (2017-2022)
Table Global Antibody-drug Conjugate Market Share Forecast by Regions (2017-2022)
Figure North America Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure Europe Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure Asia-Pacific Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure South America Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Figure Middle East & Africa Sales Antibody-drug Conjugate Market Forecast (2022-2027)
Table Global Antibody-drug Conjugate Sales Forecast by Type (2022-2027)
Table Global Antibody-drug Conjugate Market Share Forecast by Type (2022-2027)
Table Global Antibody-drug Conjugate Sales Forecast by Application (2022-2027)
Table Global Antibody-drug Conjugate Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody-drug Conjugate
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List

ImmunoGen
Takeda
Seattle Genetics
Roche

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE